GL1X · GenesisL1 explorer

MolNFT v1 · #65921 · protein

Binary and ternary crystal structures of a novel inhibitor of 17 beta- hsd type 1: a lead compound for breast cancer therapy

3HB5 · Estradiol 17-beta-dehydrogenase 1: “Binary and ternary crystal structures of a novel inhibitor of 17 beta- hsd type 1: a lead compound for breast…”. X-ray diffraction, 2 ligands (NAP, E2B), 2 pockets (best druggability 0.82). MolNFT…

PDB
3HB5
Type
protein
Length
284 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Estradiol 17-beta-dehydrogenase 1
EC
1.1.1.62
UniProt
P14061
Ligands
NAP, E2B
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XEstradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62)protein28453% helix, 15% strandP14061

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains X
  • E2B · 3-{[(9beta,14beta,16alpha,17alpha)-3,17-dihydroxyestra-1,3,5(10)-trien-16-yl]methyl}benzamide · ligand · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15990.820.8765NAP, E2B
2650.260.7115empty

Compared structures

  • 3HB5 · Binary and ternary crystal structures of a novel inhibitor of 17 beta-HSD type 1: a lead… · the same entry in another collection · chain X against X, TM-score 1.00
  • P14061 · AlphaFold monomer V2.0 prediction for 17-beta-hydroxysteroid dehydrogenase type 1 (P14061) · a predicted model of the same protein · chain X against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.